Back to Search Start Over

Thyroid dysfunction in young, first-episode and drug-naive patients with major depressive disorder: prevalence and associated clinical factors.

Authors :
Jinbo Wu
Zhunian Wang
Hongjiao Xu
Liying Yang
Jiacheng Liu
Yue Zheng
Chuanyi Kang
Xiaohong Wang
Jingjing Shi
Na Zhao
Xiang Yang Zhang
Source :
Frontiers in Psychiatry; 2023, p01-07, 7p
Publication Year :
2023

Abstract

Objective: The incidence of thyroid dysfunction (TD) and major depressive disorder (MDD) is increasing year by year in the general population. However, the prevalence and correlates of TD in first-episode drug-naive (FEDN) MDD patients have not been explored. This study sought to fill this gap and examine the association between TD and MDD. Methods: We recruited 1,289 FEDN MDD patients aged 18~45years. A total of 1,289 FEDN MDD outpatients were recruited. Demographical and suicide data were collected for each patient, and lipid profiles, thyroid function, and fasting blood glucose (FBG) levels were measured. The Hamilton Depression Scale 17 (HAMD-17) was assessed for depression. Results: The prevalence of TD in young FEDN MDD patients was 64.86%. Compared with those without TD, patients with TD had longer duration of illness, greater HAMD score, higher BMI, TG, TC, and LDL-C levels, and higher suicide attempt rates, but lower HDL-C and FBG levels. Further logistic regression indicated that duration of illness, HAMD score, TC, HDL-C, BMI, and FBG levels were significantly associated with TD. Limitations: No causal relationship can be drawn due to the cross-sectional design. Conclusion: TD is common in young FEDN MDD patients. So clinicians should monitor thyroid function in patients with MDD. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16640640
Database :
Complementary Index
Journal :
Frontiers in Psychiatry
Publication Type :
Academic Journal
Accession number :
164950589
Full Text :
https://doi.org/10.3389/fpsyt.2023.1156481